Targeted drug delivery is a therapeutic strategy that entails the precise delivery of therapeutic nanoformulations to specific tissues while minimizing systemic exposure. CD Formulation specializes in developing targeted drug delivery systems for nanoformulations, utilizing a wide range of nanocarriers. Our expertise encompasses the design and engineering of systems that incorporate nanotubes, nanowires, nanoshells, quantum dots, nanopores, gold nanoparticles, dendrimers, liposomes, niosomes, ufasomes, virosomes, cubosomes, nanobots, transferosomes, and more.
Targeted drug delivery for nanoformulations has the following significant advantages, including but not limited to improving efficacy, reducing side effects, reducing dosage, enhancing patient compliance, improving pharmacokinetics, reducing off-target effects, etc.
Fig.1 Advantages of targeting drug delivery system for nanoformulation. (CD Formulation)
Targeting of nanoformulation can be achieved through the use of nanocarrier systems, which are required to transport the drug to the target. The nanoformulation carrier captures the drug moiety and delivers it to the target site without releasing it to non-target sites. Many nanocarriers have been widely used in targeted drug delivery systems, including ufasomes, virosomes, cubosomes, nanotubes, nanowires, nanoshells, quantum dots, nanopores, gold nanoparticles, dendrimers, noisomes, nanobots, transferosomes, etc.
Fig.2 Different types of nanocarriers for drug targeting. (Prabahar, et al. 2021)
CD Formulation relies on our advanced and innovative design concept to explore and research multiple strategies for targeting drug delivery systems, such as active targeting, passive targeting, inverse targeting, double targeting, dual targeting, physical targeting, and ligand-mediated targeting.
Passive targeting is the targeting of nanoformulations to systemic drug delivery systems. It is a response of the body to the physicochemical properties of the nanoformulations or nanodrug delivery systems, which trap the drug until it reaches the target site.
In an active targeting strategy, drug delivery is accomplished by recognizing target populations on target cell receptors attached to the surface of the drug delivery system.
Reverse targeting is to avoid passive absorption of the reticuloendothelial system by drug delivery systems. We inhibit the normal absorption function by injecting large amounts of blank drug delivery systems or macromolecular dextran sulfate to saturate and inhibit the defense mechanism.
Ligand-mediated targeting relies on receptor uptake of native low-density lipoprotein particles and synthetic microemulsions of low-density lipoprotein particles coated with apolipoprotein proteins.
Physical targeting strategy aims to achieve external physical changes (including temperature changes, pH changes, and electric field changes) in nanoformulation delivery systems to allow them to be targeted to specific sites.
In the dual-targeting strategy, the nanocarriers have a synergistic effect on the entrapped drugs, thereby increasing the therapeutic efficacy.
Double targeting strategy is a combination of time and space, where spatial delivery involves targeting the nanoformulation to the target site, while temporal delivery involves controlling the release of the nanoformulation at the target site.
Fig.3 Different strategies for drug targeting. (Prabahar, et al. 2021)
CD Formulation has extensive research on the development of targeting nanoformulation formulations. Based on our advanced targeted nanodelivery system, we provide customized formulation development services for targeting nanoformulations. Our professional team has conducted in-depth research on targeting nanoformulation delivery systems and applications and is able to develop targeting nanoformulations for different purposes, thereby promoting the clinical transformation and application of targeting nanoformulations.
Technology: Stimulus-responsive drug delivery systems
Journal: Journal of Drug Delivery Science and Technology
IF: 5
Published: 2023
Results:
By using a nanoformulation of the novel anticancer drug tamoxifen (TAM) instead of chemotherapy, the toxic effects will be greatly reduced. Nanocarriers are able to carry small amounts of tamoxifen to tumors for a long time and limit their dose-dependent toxicity. At the same time, the authors have made many attempts to synthesize novel drug delivery systems from different nanomaterials such as liposomes, polymer NPs, micelles, solid lipid nanoparticles, protein-based nanoparticles, dendrimers, and other types of nanoparticles. Studies have shown that novel drug delivery systems can be synthesized by incorporating tamoxifen into these carriers with great therapeutic potential.
Fig.4 Passive delivery of TAM-containing nanocarriers to tumors through the EPR effect. (Hejin Jiang, et al. 2023)
With the development of nanotechnology and delivery strategies, nanodrug delivery systems have been widely used in targeted treatment of various diseases. The research goal of CD Formulation is to use nanodrug delivery systems to deliver precise amounts of drugs to target cells without interfering with the physiological functions of healthy cells, and to build targeted nanoformulation delivery system platform. If you require our targeting drug delivery system services for nanoformulations, please contact us.
References